Michelle McDonald
Urology · Dallas, TXNPI 1073800280
Payments from drug & device makers
What this record shows
27 manufacturers reported payments, led by Intuitive Surgical at 48.6% of the total. 2025 is the largest year on record at $2,485, more than ten times the $103 reported in 2020. That places this record below the midpoint for urology clinicians in TX, where the typical reported total is $3,394.
Across 68 payments — averaging $47.13 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$2K
- Johnson & Johnson$199
- Sumitomo Pharma America, Inc.$166
- Sanofi-aventis U.S. LLC$129
- Medtronic$115
- Tempus AI, Inc$115
- plus $924 from 21 others
What the payments were for
- Food & beverage$1,70553%
- Education$1,50047%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 6 | $1,556 |
| Johnson & Johnson | 11 | $199 |
| Sumitomo Pharma America, Inc. | 7 | $166 |
| Sanofi-aventis U.S. LLC | 1 | $129 |
| Medtronic | 5 | $115 |
| Tempus AI, Inc | 4 | $115 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $109 |
| Veloxis Pharmaceuticals, Inc. | 1 | $103 |
| AbbVie | 4 | $88 |
| Astellas Pharma US Inc | 3 | $69 |
| Antares Pharma, Inc. | 4 | $68 |
| Dendreon Pharmaceuticals LLC | 2 | $63 |
| Olympus America Inc. | 2 | $56 |
| Pfizer | 3 | $51 |
| Calyxo, Inc. | 2 | $37 |
| Procept Biorobotics Corporation | 1 | $32 |
| Inspire Medical Systems, Inc. | 1 | $28 |
| Urogen Pharma, Inc. | 1 | $27 |
| Coloplast | 1 | $27 |
| Novartis | 1 | $27 |
| Bayer | 1 | $26 |
| Mayne Pharma Commercial LLC | 1 | $23 |
| KARL Storz Endoscopy-america | 1 | $21 |
| Boston Scientific | 1 | $19 |
| Civco Medical Instruments | 1 | $18 |
| Endo USA, Inc. | 1 | $17 |
| GSK | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- DAVINCI XI$1,500
- THYMOGLOBULIN$129
- LIVTENCITY$109
- Envarsus$103
How this compares
$3,205 in reported general payments places this provider in the 45th percentile of 878 urology providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Tamsulosin Hcl | 20 | $96 |
| Finasteride | 14 | $82 |
| Atorvastatin Calcium | 23 | $56 |
Paid to pharmacies, not to this prescriber.
Other urology in Dallas
- Allen MoreyDallas$914K
- Vitaly MargulisDallas$555K
- Yair LotanDallas$371K
- Claus RoehrbornDallas$169K
- Samantha NealonDallas$89K
- Maia VandykeDallas$79K
- Gary LemackDallas$62K
- Brian LangfordDallas$57K
- Jonathan SeamanDallas$55K
- Andrew von EschenbachMontgomery$3.2M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.